(5-Bromopyridin-2-yl)(morpholino)methanone, 98%, 1g

N-[(9H-Fluoren-9-ylmethoxy)carbonyl]-L-tyrosine>95.0%(T)(HPLC)5g

4-Methoxy-2-nitrophenol>98.0%(GC)(T)5g

3-(3-Fluorophenyl)-1H-pyrazole-4-carboxylic acid, 97.0%, 250mg

4-CHLORO-5-METHOXY-6-METHYLPYRIMIDINE, 95%, 5g

3-Bromo-9-methoxy-5,6,7,8-tetrahydropyrazolo[5,1-b]quinazoline, 95.0%, 250mg

5-FLUORO-6-METHOXYPYRIDIN-3-OL, 95%, 5g

beta-L-Aspartyl-L-phenylalanine methyl ether, 99.0%, 5g

(1-Methyl-1H-benzo[d]imidazol-6-yl)methanol, 95.0%, 1g

3,5-Dimethyl-4-(pyrrolidin-1-ylsulfonyl)-1H-pyrazole, 95.0%, 500mg

5,5'-dithio-bis-(-2-nitrobenzoic acid), mínimo 98 %, pa, 5 g, envase de vidrio

2-(4,4-Dimethyl-4,5-dihydro-oxazol-2-yl)-3-methyl-pyridine, 95.0%, 1g

2-Naphthol>99.0%(GC)250g